P189 Efficacy and safety of upadacitinib maintenance treatment in patients with moderately to severely active crohn’s disease: 3-year results from U-ENDURE
E-Posters | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: A198.1-A198
10.1136/gutjnl-2026-bsg.315